Trial Profile
Symproic Tablets 0.2mg drug use-results survey
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 19 May 2022
Price :
$35
*
At a glance
- Drugs Naldemedine (Primary)
- Indications Constipation
- Focus Adverse reactions; Therapeutic Use
- Sponsors Shionogi
- 08 Jun 2018 New trial record